The tariff classification of Risedronate Sodium (CAS-115436-72-1) in bulk form, from Italy and Timolol Maleate (CAS-26921-17-5) in bulk form, from Taiwan

N102043 April 28, 2010 CLA-2-29:OT:RR:NC:N2:238 CATEGORY: Classification TARIFF NO.: 2933.39.4100; 2934.99.4700 Ms. Inge Forstenzer Ren-Pharm International, Ltd. 350 Jericho Turnpike, Suite 204 Jericho, NY 11753 RE: The tariff classification of Risedronate Sodium (CAS-115436-72-1) in bulk form, from Italy and Timolol Maleate (CAS-26921-17-5) in bulk form, from Taiwan Dear Ms. Forstenzer: In your letter dated April 16, 2010, you requested a tariff classification ruling. The first product, Risedronate Sodium, is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism. It is indicated for the treatment and prevention of osteoporosis in postmenopausal women The second product, Timolol Maleate, is a non-selective beta-adrenergic receptor blocking agent. It is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. The applicable subheading for the Risedronate Sodium, imported in bulk form will be 2933.39.4100, which provides for “Heterocyclic compounds with nitrogen hetero-atom(s) only: Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: Other: Other: Drugs: Other.” Pursuant to General Note 13, HTSUS, the rate of duty will be free. The applicable subheading for the Timolol Maleate, imported in bulk form will be 2934.99.4700 which provides for “Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds: Other: Other: Other: Drugs.” Pursuant to General Note 13, HTSUS, the rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at (646) 733-3033. Sincerely, Robert B. Swierupski Director National Commodity Specialist Division